Omicron poses near-term risks to Asia as it comes amidst stretched supply chains, inflation
DeeperDive is a beta AI feature. Refer to full articles for the facts.
JUST as many countries are reopening their borders, the emergence of Omicron is threatening to derail global recovery from a two-year pandemic, but economists are sanguine that the downside risk to Asia's growth may be limited due to high vaccination rates.
In its latest report "Assessing the risks from the new Covid variant", Morgan Stanley economists, led by chief Asia economist Chetan Ahya, say this is provided the new Covid-19 variant is not more challenging than Delta variant, which became the world's dominant strain after emerging in India late last year.
"Relative to the outbreak of the Delta variant in Asia in mid-2021, we now have much higher levels of vaccination. Out of 12 economies, 10 already have at least 70 per cent of their population inoculated with one dose of vaccine," Morgan Stanley says.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Three directors linked to Kweks’ father-son feud quit Millennium & Copthorne board
COEs: Mainstream car category tops bidding at S$123,010 as demand ‘just too strong’
New CPF life-cycle investment scheme could channel up to S$9 billion a year into Singapore stocks: Citi
Middle East-linked energy supply shocks put Asean Power Grid back in focus